17.12.2021 • NewsClariantBASF

Clariant Joins German Hydrogen Project

Clariant Catalysts is participating in Germany’s TransHyDE project AmmoRef, which aims to develop technologies and catalysts for ammonia cracking to facilitate future hydrogen transport.

Marvin Estenfelder, head of R&D at Clariant Catalysts, said the company has been involved in R&D and cross-industry collaborations in this area for many years and has already developed numerous catalysts for use in innovative hydrogen applications. “We are confident that together we will make it possible to recover pure hydrogen from ammonia in the scales required for efficient and safe mass transportation of hydrogen,” he said.

Although green hydrogen is an abundant and clean energy source, its high volatility and very low density make it difficult and expensive to transport. An economically viable method is to convert hydrogen to ammonia for transportation and release it at the point of use. The release is achieved by cracking (dissociation) of ammonia into hydrogen.

(c) Clariant
(c) Clariant

There are commercial processes and catalysts available currently, but at relatively high energy costs. AmmoRef aims to develop new catalysts and technologies for ammonia dissociation at lower energy costs and improved efficiency.

Clariant’s role is to develop new and improved generations of its existing ammonia cracking catalysts. It will be collaborating non-exclusively with industry partners BASF and ThyssenKrupp, as well as the Max Planck Institute and some German universities.

Author: Elaine Burridge, Freelance Journalist

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read